Phase 1 study on safety and PK of rovalpituzumab tesirine (Rova-T) in Japanese patients with advanced, recurrent SCLC

Kentaro Tanaka, Hibiki Udagawa, Hiroaki Akamatsu, Masayuki Takeda, Shintaro Kanda, Ikuko Yasuda, Sumiko Okubo, Shekman Wong, Charity Scripture, Tomohide Tamura, Isamu Okamoto

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)vii57
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
Publication statusPublished - Oct 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this